Search for: "HOLDER v. WYETH" Results 1 - 20 of 70
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jan 2010, 10:41 am by Dennis Crouch
Links: PTA Statistics Patent Maintenance Fee Payments USPTO Re-Calculating PTA Wyeth v. [read post]
23 Oct 2012, 6:30 am by Matthew Gilpin
Wyeth Inc. and In re Lamictal Direct Purchaser Antitrust LitigationThe settlement agreements challenged in Professional Drug Co. v. [read post]
21 Jun 2010, 1:22 pm by Lyle Denniston
The case of Wyeth LLC te al., v. [read post]
6 Oct 2010, 4:22 am by Kelly
Highlights this week included: Prezista (Darunavir) – US NIH becomes first patent holder to join UNITAID Medicines Patent Pool (IP Watch) (KEI) Taxotere (Docetaxel) – US: District Court finds Sanofi’s Taxotere invalid: Aventis v Hospira (Patent Docs) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
8 Feb 2009, 9:02 pm
We thank him for the contribution, and the credit for what follows naturally goes to Bert alone:As we anticipate decision in Wyeth v. [read post]
22 Oct 2009, 12:19 pm by Dennis Crouch
The outcome of these cases will likely be dictated by the Federal Circuit's decision in Wyeth v. [read post]
11 Apr 2016, 1:41 pm
 All holders of marketing applications for biological products have an  ongoing obligation to ensure their labeling is accurate and up to date.Biosimilar Labeling Draft Guidance at 10-11 (footnote omitted).So we took a look at §601.12, although we had a pretty good idea what we would find – a “changes being effected” provision (§601.12(f)(2)(i)) quite similar to the one that defeated preemption in Wyeth v. [read post]